Introduction: Checkpoint Inhibition in Non-Small Cell Lung Cancer
0 Views
administrator
07/14/23
Moderator Corey J. Langer, MD, introduces a panel discussion focused on frontline treatment approaches and evolving maintenance strategies for patients with advanced non-small cell lung cancer, including discussion on immunotherapy, second-generation TKIs, and molecular medicine. The conversation includes in-depth perspective from Mark G. Kris, MD, Benjamin P. Levy, MD, Mark A. Socinski, MD, and Heather A. Wakelee, MD.
-
Category
Show more
Facebook Comments
No comments found